Navigation Links
Express Scripts To Discuss Outlook for Future Growth
Date:7/25/2013

ST. LOUIS, July 25, 2013 /PRNewswire/ -- As previously announced, Express Scripts Holding Company (Nasdaq: ESRX) will release its second quarter earnings on Monday, July 29, 2013 after the market closes and will hold its quarterly conference call to discuss second quarter earnings results on Tuesday, July 30, 2013, at 8:30 a.m. Eastern Time (7:30 a.m. Central Time). This call is being webcast and can be accessed from the Investor Information section of Express Scripts' web site at www.express-scripts.com/corporate

In addition to a discussion of second quarter earnings results and 2013 guidance update, the conference call is expected to include a discussion on drivers of future growth for the industry as well as a discussion of the longer-term growth potential specific to Express Scripts.  A slide presentation will accompany the webcast.  Following the conference call, both the slide presentation and the webcast will remain available on the Investor Information section of Express Scripts website for 14 days.  RealPlayer or Windows Media Player is needed to listen to the webcast and free downloads of these players are available at the webcast site.

About Express Scripts

Express Scripts (NASDAQ: ESRX) manages more than a billion prescriptions each year for tens of millions of patients. On behalf of our clients – employers, health plans, unions and government health programs – we make the use of prescription drugs safer and more affordable. Express Scripts uniquely combines three capabilities – behavioral sciences, clinical specialization and actionable data – to create Health Decision Science(SM), our innovative approach to help individuals make the best
'/>"/>

SOURCE Express Scripts
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Express Scripts to Present at Bank of America Merrill Lynch Conference
2. Generex Announces Presentations of Antigen Express AE37 Breast Cancer Vaccine Data at ASCO 2012
3. Ceregene Parkinsons Disease Study Demonstrates Long-term Neurturin Expression and Enhanced Dopamine Activity 4 Years Following Delivery of CERE-120 (AAV2-neurturin)
4. Generex Announces New Members of Antigen Express Scientific Advisory Board for the AE37 Breast Cancer Vaccine
5. Generex Augments Antigen Express Scientific Advisory Board
6. Law Office of Brodsky & Smith, LLC Announces Investigation of SRI Surgical Express, Inc.
7. Generex Announces OncUView.tv Interviews Featuring the Antigen Express AE37 Breast Cancer Vaccine at ASCO 2012
8. Selexis Lubris Partnership Advances Difficult-to-Express Protein Towards Clinic
9. Express Scripts Holding Company Announces Second Quarter 2012 Earnings Conference Call
10. Sigma-Aldrich Accelerates Analytical Research and Extends Benefits of Fused-Core Particle Technology to All HPLC Users with the Launch of New Ascentis Express 5 Micron Particle by Supelco
11. Express Scripts Reports Second Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... NEW YORK , Sept. 16, 2014  Relmada ... therapies for the treatment of chronic pain, announced today ... Sloan Kettering Cancer Center (MSKCC) in a series of ... ER, a new tamper-resistant, extended release form of levorphanol. ... investigator for these studies. Dr. Pasternak ...
(Date:9/15/2014)... NEW YORK , Sept. 16, 2014 ... Neuropathy Foundation (HNF) announced today an agreement to collaborate ... disease and support the development of a stronger CMT ... provide financial support to several HNF,s initiatives including: ... section in the HNF website featuring  HNF newsletters, materials ...
(Date:9/15/2014)... , Sept. 15, 2014 /PRNewswire/ -  Pivotal Therapeutics ... specialty pharmaceutical company with a focus on Omega-3 ... today that the Board of Directors approved the ... an advisor at the close of business on Friday, ... of 1,000,000 common shares of the Company were ...
Breaking Medicine Technology:Relmada Therapeutics Enters Into Agreement with Memorial Sloan Kettering to Better Clarify Unique Mechanism of Action for LevoCap ER 2Relmada Therapeutics Enters Into Agreement with Memorial Sloan Kettering to Better Clarify Unique Mechanism of Action for LevoCap ER 3Pharnext and the Hereditary Neuropathy Foundation Collaborate to Increase Awareness of Charcot-Marie-Tooth Disease 2Pharnext and the Hereditary Neuropathy Foundation Collaborate to Increase Awareness of Charcot-Marie-Tooth Disease 3Pharnext and the Hereditary Neuropathy Foundation Collaborate to Increase Awareness of Charcot-Marie-Tooth Disease 4Pivotal Therapeutics Grants Incentive Stock Options 2
... ... ... ... ...
... ... ... ... ...
Cached Medicine Technology:FTC Bars Transitions Optical, Inc. from Using Anticompetitive Tactics to Maintain its Monopoly in Darkening Treatments for Eyeglass Lenses 2FTC Bars Transitions Optical, Inc. from Using Anticompetitive Tactics to Maintain its Monopoly in Darkening Treatments for Eyeglass Lenses 3FTC Bars Transitions Optical, Inc. from Using Anticompetitive Tactics to Maintain its Monopoly in Darkening Treatments for Eyeglass Lenses 4FTC Bars Transitions Optical, Inc. from Using Anticompetitive Tactics to Maintain its Monopoly in Darkening Treatments for Eyeglass Lenses 5FTC Bars Transitions Optical, Inc. from Using Anticompetitive Tactics to Maintain its Monopoly in Darkening Treatments for Eyeglass Lenses 6FTC Bars Transitions Optical, Inc. from Using Anticompetitive Tactics to Maintain its Monopoly in Darkening Treatments for Eyeglass Lenses 7FTC Bars Transitions Optical, Inc. from Using Anticompetitive Tactics to Maintain its Monopoly in Darkening Treatments for Eyeglass Lenses 8FTC Bars Transitions Optical, Inc. from Using Anticompetitive Tactics to Maintain its Monopoly in Darkening Treatments for Eyeglass Lenses 9FTC Bars Transitions Optical, Inc. from Using Anticompetitive Tactics to Maintain its Monopoly in Darkening Treatments for Eyeglass Lenses 10FTC Bars Transitions Optical, Inc. from Using Anticompetitive Tactics to Maintain its Monopoly in Darkening Treatments for Eyeglass Lenses 11Rapid Review Imaging System From P&R Dental Strategies Assures Fast, Accurate and Efficient Dental Claim Review 2Rapid Review Imaging System From P&R Dental Strategies Assures Fast, Accurate and Efficient Dental Claim Review 3Rapid Review Imaging System From P&R Dental Strategies Assures Fast, Accurate and Efficient Dental Claim Review 4Rapid Review Imaging System From P&R Dental Strategies Assures Fast, Accurate and Efficient Dental Claim Review 5Rapid Review Imaging System From P&R Dental Strategies Assures Fast, Accurate and Efficient Dental Claim Review 6
(Date:9/16/2014)... September 16, 2014 Wholelifeinsurancecompanies.org has released ... find life insurance with a bad heart condition. , ... find affordable life insurance if they compare quotes. Most ... the decision depend on the actual and past medical ... that caused several heart attacks in the past, his ...
(Date:9/16/2014)... positron emission tomography (PET) tracer is effective in diagnosing ... according to a case study conducted at the Icahn ... Neuroimaging (MNI) LLC in New Haven, and published September ... Specifically, the study results suggest that an experimental radiolabeled ... onto a protein called tau that accumulates in the ...
(Date:9/16/2014)... soon better predict a man,s risk of getting prostate ... the largest-ever analysis of the cancer,s genetic biomarkers, reported ... of Health and Biomedical Innovation,s Dr Jyotsna Batra and ... in the large consortia of research hubs around the ... genetic markers in 80,000 men. , "It,s the largest ...
(Date:9/16/2014)... York, NY (PRWEB) September 16, 2014 ... in diagnosing concussion-related brain disease while a person is ... the Icahn School of Medicine at Mount Sinai, and ... published September 16 in the journal Translational Psychiatry. , ... compound called [18 F]-T807, which is designed to latch ...
(Date:9/16/2014)... 16, 2014 The Muscular Dystrophy ... flu vaccines for individuals affected by muscle disease, ... other neuromuscular diseases. , MDA offers this service ... disease who, because of compromised respiratory function — ... lungs — are at increased risk of serious ...
Breaking Medicine News(10 mins):Health News:No Exam Life Insurance for Clients Who Have a Bad Heart Condition! 2Health News:Neuroimaging technique identifies concussion-related brain disease in living brain 2Health News:Neuroimaging technique identifies concussion-related brain disease in living brain 3Health News:New gene research helps pinpoint prostate cancer risk 2Health News:Neuroimaging Technique Identifies Concussion-Related Brain Disease in Living Brain 2Health News:Neuroimaging Technique Identifies Concussion-Related Brain Disease in Living Brain 3Health News:Neuroimaging Technique Identifies Concussion-Related Brain Disease in Living Brain 4Health News:MDA Offers Flu Shots to Those Affected by Muscle Disease 2
... and vegetable juice could stave off Alzheimer's disease, say ... in the skin and peels of fruits and vegetables. ... ,Lab trials have earlier shown that polyphenols can ... to significantly delay the onset of serious cognitive impairment. ...
... silent killer worldwide and it is imperative to make people aware ... to be taken, say medical experts.// ,Now in its third ... to increase awareness about hepatitis B and C. The theme for ... silent disease. Most of the people are unaware that they have ...
... economic, social and health factors affecting African Americans, Penn ... Black’//. , ,Dr. Shaun Gabbidon, associate professor of ... and public policy, both at Penn State's Harrisburg campus, ... the Journal of Black Studies. , ,"There are ...
... among eighty countries has found that the Iraqi public portrays ... // out-groups. Ethnic solidarity seems to be at an all ... on restoration of order and security, along with emergence of ... embittered and torn Iraqi nation. The analysis is an outcome ...
... starches and sugars with unhealthy high-fat foods? A new ... ,A recent study of an internet-based support ... for dieters on low-carbohydrate diets has been the addition ... carbohydrates removed from their diet. The report was published ...
... antibiotic shows early promise as an anti-cancer agent, inhibiting ... tumors, // according to researchers at the University of ... appear in the Oct. 1 issue of Cancer Research. ... to be over-expressed in cancer cells to screen for ...
Cached Medicine News:Health News:Awareness Must to Tackle Hepatitis: Experts 2Health News:Understanding Stress Triggers for African Americans 2Health News:Iraqi’s Gripped with Insecurit 2Health News:Iraqi’s Gripped with Insecurit 3Health News:Low-Carb Dieters Eat More Vegetables 2Health News:Antibiotic Inhibits Cancer Gene Activity 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: